Home - Products - Others - Other Targets - Hoechst 33342 trihydrochloride

Hoechst 33342 trihydrochloride

CAS No. 875756-97-1

Hoechst 33342 trihydrochloride( bisBenzimide H 33342 trihydrochloride,HOE 33342 trihydrochloride )

Catalog No. M22372 CAS No. 875756-97-1

Hoechst 33342 trihydrochloride is a membrane permeant blue fluorescent DNA stain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 44 In Stock
50MG 65 In Stock
100MG 93 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hoechst 33342 trihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Hoechst 33342 trihydrochloride is a membrane permeant blue fluorescent DNA stain.
  • Description
    Hoechst 33342 trihydrochloride is a membrane permeant blue fluorescent DNA stain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    bisBenzimide H 33342 trihydrochloride,HOE 33342 trihydrochloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    875756-97-1
  • Formula Weight
    561.93
  • Molecular Formula
    C27H31Cl3N6O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:46 mg/mL (81.86 mM); H2O:5.6 mg/mL (9.97 mM)
  • SMILES
    Cl.Cl.Cl.CCOc1ccc(cc1)-c1nc2ccc(cc2[nH]1)-c1nc2ccc(cc2[nH]1)N1CCN(C)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chazotte B. Labeling nuclear DNA with hoechst 33342. Cold Spring Harb Protoc. 2011 Jan 1;2011(1):pdb.prot5557.
molnova catalog
related products
  • Prolactin Releasing ...

    Prolactin Releasing Peptide (12-31), bovine

  • Lodelcizumab

    Lodelcizumab (LGT 209) is a monoclonal antibody targeting the preprotein convertase Bacillus subtilis protease Kexin-9 (PCSK9) and is used to study hypercholesterolemia.

  • Carbaglu

    Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death.